Axio BioPharma
PrivateLast Round
Pre Seed
Sep 21, 2026
Total Funding Raised
$2.45M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Axio BioPharma operates in Healthcare & Life Sciences and is based in Madison, Wisconsin. Its latest recorded funding round was a Pre Seed round in September 2026.
Axio BioPharma is a biotechnology company that operates as a Contract Development and Manufacturing Organization (CDMO) transforming biopharmaceutical manufacturing by using AI to accelerate the development of mammalian-expressed recombinant proteins, with a focus on monoclonal antibodies (mAbs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axio BioPharma Comparables
Compare Axio BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbInitio Bio | 79% | |
| Culture Biosciences | 74% | |
| Algocell | 73% |
For institutional investors. Book with your work email.
Axio BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Sep 21, 2026 | ||||
| Grant | Feb 3, 2026 | ||||
| Seed | Sep 2, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axio BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemical Angel Network | Seed, Pre Seed |
| Chisos Capital | Seed, Pre Seed |
| BioForward Wisconsin | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2026
Partnered with Shimadzu to optimize cell culture media.
- Sep 21, 2026
$2.4M raised from Chemical Angel Network and Chisos Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 6, 2026
Axio BioPharma Inc. and Shimadzu collaborate to combine Shimadzu’s CellTune Ver.2 software and Media Blending Kit with Axio BioPharma Inc.’s laboratory capabilities in Wisconsin to evaluate AI- and data-guided media optimisation workflows.
- receives_financingSep 25, 2026
Axio BioPharma Inc. receives a $2.4M Pre Seed funding round on Nov 3rd '26 in Wisconsin to support biomanufacturing data connectivity and platform development.
For institutional investors. Book with your work email.
Axio BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axio BioPharma's valuation, stock price, and market status.
Is Axio BioPharma a public or private company?
Axio BioPharma is a private company.
What is the current stock price of Axio BioPharma?
Axio BioPharma is a private company, so its shares have no public market price. Caplight tracks Axio BioPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axio BioPharma worth (valuation)?
Valuation information for Axio BioPharma is not publicly available.
Can I buy Axio BioPharma stock?
Axio BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axio BioPharma's last funding round?
Axio BioPharma's most recent funding round was Pre Seed on September 21, 2026.
Who are the main investors in Axio BioPharma?
Key investors in Axio BioPharma include Chemical Angel Network, Chisos Capital, BioForward Wisconsin.
Will Axio BioPharma IPO soon?
No public IPO plans have been announced for Axio BioPharma.
How can I track Axio BioPharma secondary market activity?
Caplight tracks bids, offers, and trades in Axio BioPharma's shares on secondary markets.